LEADER 01644nam--2200373---450- 001 990000760030203316 005 20090226105316.0 035 $a0076003 035 $aUSA010076003 035 $a(ALEPH)000076003USA01 035 $a0076003 100 $a20011121d1990----km-y0itay0103----ba 101 $iita 102 $aIT 105 $a||||||||001yy 200 1 $aDisposizioni per la formazione del bilancio annuale e pluriennale dello Stato (legge finanziaria 1990) (legge 27 dicembre 1989 N.407) e bilancio di previsione dello Stato per l'anno finanziario 1990 e bilancio pluriennale per il triennio 1990-1992 (legge 27 dicembre 1989 n.409) 210 $aRoma$cIstituto poligrafico e Zecca dello Stato$d1990 215 $a1005 p.$d29 cm 300 $aIn testa al front.: Ministero del tesoro, Ragioneria generale dello Stato 410 $12001 676 $a353.00722 710 01$aItalia$b: Ragioneria dello Stato$0550051 801 0$aIT$bsalbc$gISBD 912 $a990000760030203316 951 $a353.007 ITA 7 (IEP VI 156/1990)$bEC$cIEP$dOO199287 959 $aBK 969 $aECO 979 $aPATTY$b90$c20011121$lUSA01$h1607 979 $aPATTY$b90$c20011121$lUSA01$h1609 979 $c20020403$lUSA01$h1723 979 $aPATRY$b90$c20040406$lUSA01$h1652 979 $aRSIAV4$b90$c20090226$lUSA01$h1053 996 $aDisposizioni per la formazione del bilancio annuale e pluriennale dello Stato (legge finanziaria 1990) (legge 27 dicembre 1989 N.407) e bilancio di previsione dello Stato per l'anno finanziario 1990 e bilancio pluriennale per il triennio 1990-1992 (legge 27 dicembre 1989 n.409$9964619 997 $aUNISA LEADER 05395nam 2200685Ia 450 001 9911019150703321 005 20200520144314.0 010 $a9786612123665 010 $a9781282123663 010 $a1282123661 010 $a9780470745465 010 $a0470745460 010 $a9780470745458 010 $a0470745452 035 $a(CKB)1000000000719711 035 $a(EBL)427958 035 $a(SSID)ssj0000354420 035 $a(PQKBManifestationID)11273861 035 $a(PQKBTitleCode)TC0000354420 035 $a(PQKBWorkID)10322574 035 $a(PQKB)11567099 035 $a(MiAaPQ)EBC427958 035 $a(OCoLC)352789951 035 $a(Perlego)2770918 035 $a(EXLCZ)991000000000719711 100 $a20090116d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aManagement of acute coronary syndromes /$fEli V. Gelfand and Christopher P. Cannon 210 $aChichester, West Sussex ;$aHoboken, NJ $cJohn Wiley & Sons$d2009 215 $a1 online resource (242 p.) 300 $aDescription based upon print version of record. 311 08$a9780470725573 311 08$a0470725575 320 $aIncludes bibliographical references and index. 327 $aManagement of Acute Coronary Syndromes; Contents; List of contributors; Foreword; Chapter 1 Pathophysiology of acute coronary syndromes; Introduction; Formation of atherosclerotic plaque; Plaque instability and the development of ACS; Myocardial ischemia; Thrombus formation; Platelets; Secondary hemostasis; Dynamic obstruction; Progressive mechanical obstruction; Inflammation; Secondary unstable angina; References; Chapter 2 Diagnosis of acute coronary syndrome; Introduction; Definition of myocardial infarction; History; Risk factors; Physical examination; Electrocardiography 327 $aThe pathophysiologic basis of ST segment changes during ischemiaElectrocardiography in ST-elevation MI and identification of the infarct-related artery; Electrocardiography in unstable angina and NSTEMI; Cardiac biomarkers; Noninvasive imaging; Echocardiography; Myocardial perfusion imaging; Coronary computed tomography; Cardiovascular magnetic resonance imaging; Stress testing for diagnosis of ACS; Overall diagnostic pathway for ACS; References; Chapter 3 Unstable angina and non-ST-elevation myocardial infarction; Introduction; Causes of UA/NSTEMI; Presentation of UA/NSTEMI 327 $aGeneral strategies in management of UA/NSTEMIRisk stratification of patients with UA/NSTEMI; Initial management of UA/NSTEMI in the emergency department; Pharmacologic treatment of ischemia in UA/NSTEMI; Beta-blockers; Nitrates; Calcium channel blockers; Angiotensin-converting enzyme inhibitors; Morphine; Oxygen; Invasive versus conservative strategy; Antiplatelet therapy in UA/NSTEMI; Aspirin; Clopidogrel; Prasugrel; Glycoprotein IIb/IIIa inhibitors; Anticoagulant therapy in UA/NSTEMI; Unfractionated heparin; Enoxaparin; Direct thrombin inhibitors; Fondaparinux 327 $aOral anticoagulation in UA/NSTEMIFibrinolysis in UA/NSTEMI; Early lipid-lowering therapy in patients with UA/NSTEMI; Predischarge noninvasive risk stratification after UA/NSTEMI; Overall management of UA/NSTEMI; References; Chapter 4 ST-segment-elevation myocardial infarction; Introduction; Global treatment goals in STEMI; Prehospital management and triage; Transport decisions; Management prior to reperfusion; Primary reperfusion therapy for STEMI; Fibrinolysis; Combination fibrinolysis; Markers of fibrinolysis effectiveness; Complications of fibrinolysis 327 $aPrimary percutaneous coronary interventionComparison of PCI with fibrinolysis; Timing of primary PCI; PCI following fibrinolytic therapy; Rescue PCI; Facilitated PCI; Routine PCI after successful fibrinolysis; Overall reperfusion strategy; Coronary artery bypass grafting for treatment of STEMI; Adjunctive pharmacologic treatment of STEMI; Antiplatelet agents; Anticoagulation therapy; Other adjunctive therapy; Hospital care following successful reperfusion; References; Chapter 5 Special considerations in acute coronary syndromes; Secondary unstable angina 327 $aAcute coronary syndrome in patients with diabetes mellitus 330 $aAcute Coronary Syndrome covers the spectrum of clinical conditions ranging from unstable angina to non-ST elevation myocardial infarction and ST elevation myocardial infarction. These life-threatening disorders are a major cause of emergency medical care, hospitalization and mortality. Management of Acute Coronary Syndromes is designed to provide busy clinicians with a comprehensive guide to the investigation, diagnosis and treatment of these syndromes. It encompasses the latest technologies, including the use of biomarkers and non-invasive imaging procedures. For each condition, t 606 $aCoronary heart disease 606 $aMyocardial infarction 615 0$aCoronary heart disease. 615 0$aMyocardial infarction. 676 $a616.123 676 $a616.12306 700 $aGelfand$b Eli V$01840446 701 $aCannon$b Christopher P$01840447 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019150703321 996 $aManagement of acute coronary syndromes$94420000 997 $aUNINA